NCT05689333View on ClinicalTrials.gov

A Study to Evaluate the Safety and Performance of the Vista Probe for Vitrectomy Surgery

NACompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

December 9, 2022

Primary Completion Date

May 7, 2024

Study Completion Date

May 7, 2024

Conditions
Vitrectomy
Interventions
DEVICE

Vista Vitrectomy Probe

Vitrectomy will be performed through 27 GA Vista Ophthalmics vitrector

Trial Locations (4)

19004

CBCC Global Research Site:001, Bala-Cynwyd

34209

CBCC Global Research Site:002, Bradenton

78503

CBCC Global Research Site:004, McAllen

90067

CBCC Global Research Site:003, Los Angeles

Sponsors

Collaborators (1)

CBCC Global Research
All Listed Sponsors
collaborator

CBCC Global Research

NETWORK

lead

VISTA Ophthalmics

INDUSTRY

NCT05689333 - A Study to Evaluate the Safety and Performance of the Vista Probe for Vitrectomy Surgery | Biotech Hunter | Biotech Hunter